2007
DOI: 10.1016/j.neuroscience.2007.04.016
|View full text |Cite
|
Sign up to set email alerts
|

P2 purinoceptor antagonists inhibit the non-adrenergic, non-cholinergic relaxation of the human colon in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
12
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(18 citation statements)
references
References 49 publications
6
12
0
Order By: Relevance
“…We cannot find any obvious reason for this discrepancy. Another surprising finding of the present series of experiments was that a combination of PPADS and suramin, a treatment that was effective in reducing the NANC relaxation in the human colonic circular muscle under similar conditions (Benko et al 2007), failed to inhibit that in the small intestine. Further studies are clearly needed to compare the purinoceptor antagonist spectra of MRS 2179 and the PPADS + suramin combination.…”
Section: Discussionmentioning
confidence: 55%
See 1 more Smart Citation
“…We cannot find any obvious reason for this discrepancy. Another surprising finding of the present series of experiments was that a combination of PPADS and suramin, a treatment that was effective in reducing the NANC relaxation in the human colonic circular muscle under similar conditions (Benko et al 2007), failed to inhibit that in the small intestine. Further studies are clearly needed to compare the purinoceptor antagonist spectra of MRS 2179 and the PPADS + suramin combination.…”
Section: Discussionmentioning
confidence: 55%
“…A combination of the P 2 purinoceptor antagonists PPADS (50 μM) and suramin (100 μM) was used in the experiments of Undi et al (2006) and Benko et al (2007) for studying a participation of purinergic mechanisms in the NANC relaxation of the CM of the human ileum and sigmoid colon, respectively. This combination of antagonists was more effective than either substance alone.…”
Section: Introductionmentioning
confidence: 99%
“…(5,31). However, 2Ј-deoxy-N 6 -methyl adenosine 3Ј,5Ј-diphosphate tetraammonium salt (MRS 2179), which is the N 6 -methyl modification of 2Ј-deoxyadenosine 3Ј,5Ј-bisphosphate, is a potent P2Y 1 receptor antagonist (8) and is presently considered competitive and specific (1,19).…”
mentioning
confidence: 99%
“…Inhibitory neuromuscular transmitters in the enteric nervous system (ENS) include nitric oxide (NO)(He et al, 1993; Osthaus and Galligan, 1992; Sanders et al, 1992; Smits and Lefebvre, 1996) and one or more purinergic neurotransmitters (Burnstock, 2008; Crist et al, 1992; Durin et al, 2014; Huang et al, 2001; Mutafova-Yambolieva and Durin, 2014; Mutafova-Yambolieva et al, 2007; Smits and Lefebvre, 1996). The purinergic neurotransmitter acts at P2Y 1 receptors on GI smooth muscle (Benko et al, 2007; De Man et al, 2003; Gallego et al, 2006; Wang et al, 2007) and PDGF-α positive fibroblast-like cells (Kurashi et al, 2011, 2014). P2Y 1 receptors link to Ca 2+ release from intracellular stores and P2Y 1 receptor activation causes fast inhibitory junction potentials (IJPs) and relaxation (Benko et al, 2007; Gallego et al, 2006; Wang et al, 2007; Zhang et al, 2010).…”
mentioning
confidence: 99%
“…The purinergic neurotransmitter acts at P2Y 1 receptors on GI smooth muscle (Benko et al, 2007; De Man et al, 2003; Gallego et al, 2006; Wang et al, 2007) and PDGF-α positive fibroblast-like cells (Kurashi et al, 2011, 2014). P2Y 1 receptors link to Ca 2+ release from intracellular stores and P2Y 1 receptor activation causes fast inhibitory junction potentials (IJPs) and relaxation (Benko et al, 2007; Gallego et al, 2006; Wang et al, 2007; Zhang et al, 2010). IJPs result from Ca 2+ -induced activation of apamin-sensitive small-conductance Ca 2+ -dependent K + channels (SK channels)(Crist et al, 1992; Pascuad et al, 1996; Wang et al, 2007; Zhang et al, 2010).…”
mentioning
confidence: 99%